60 filings
Page 2 of 3
10-K
5391jxh3oz7dhbjd3583
16 Apr 24
Annual report
4:48pm
S-8
y5ixuo7nqcqoa wfq
12 Apr 24
Registration of securities for employees
7:22pm
8-K
qzzsutuy09p10m6vxoe
9 Apr 24
Chromocell Issues Letter to Stockholders from Chief Executive Officer
8:30am
NT 10-K
2f7js 7tnsr3kgr
1 Apr 24
Notice of late annual filing
9:00am
8-K
3x8dhclz
21 Mar 24
Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler
9:00am
8-K
02c1 ejx96
18 Mar 24
Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023
4:05pm
8-K
jnpycwz
13 Mar 24
Regulation FD Disclosure
8:00am
8-K
34hn5rn
22 Feb 24
Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
4:05pm
424B4
sfg2h1
20 Feb 24
Prospectus supplement with pricing info
5:30pm
424B4
plsitofk
20 Feb 24
Prospectus supplement with pricing info
5:28pm
SEC STAFF
icc2qva
20 Feb 24
SEC staff action: Order
12:00am
POS EX
7045sh ujdn
15 Feb 24
Additional exhibits for listing
9:56pm
CERT
fp1qa4676y54c8
15 Feb 24
Certification of approval for exchange listing
11:46am
8-A12B
vo70v topo
15 Feb 24
Registration of securities on exchange
11:35am
EFFECT
zofb07beqc1h 5cch
15 Feb 24
Notice of effectiveness
12:15am
FWP
kum15x1q37e9up80s
12 Feb 24
Free writing prospectus
8:09am
CORRESP
it8b70e3 cig
12 Feb 24
Correspondence with SEC
12:00am
CORRESP
1ffq4z hw
12 Feb 24
Correspondence with SEC
12:00am